Literature DB >> 21153508

Delayed recovery of myocardial blood flow after intracoronary stem cell administration.

Mariann Gyöngyösi1, Rayyan Hemetsberger, Susanne Wolbank, Valentin Pichler, Christoph Kaun, Aniko Posa, Zsolt Petrasi, Örs Petnehazy, Renate Hofer-Warbinek, Rainer de Martin, Florian Gruber, Imre Benedek, Teodora Benedek, Istvan Kovacs, Istvan Benedek, Christian A Plass, Silvia Charwat, Gerald Maurer.   

Abstract

The aim of the present study was to investigate the changes in absolute myocardial blood flow (AMF) after intracoronary injections of mesenchymal SC (MSC) and compared to controls in closed-chest reperfused acute myocardial infarction (AMI) in pigs. Male MSCs, transiently transfected with Luciferase (Luc-MSC) were delivered (9.7 ± 1.2 x 10(6)) intracoronary in the open infarct-related artery one-week post-AMI in female pigs (group MSC), while saline was injected with the same injection rate in controls (group C). The AMF was measured immediately after, and 3, 12 and 24 h post-intracoronary Luc-MSC or saline injections. In vitro bioluminescence images and quantitative real-time TaqMan PCR measurements were performed to quantify the sex-mismatched MSCs. No difference between the groups was observed regarding the weight, heart rate, blood pressure and global ejection fraction 1-week post-AMI. The baseline AMF were similar in the groups (61.3 ± 15. vs 61.1 ± 12.0 ml/min). AMF was decreased significantly immediately after intracoronary MSC delivery (42.0 ± 12.4 vs 57.7 ± 15.7 ml/min p = 0.013), and remained low at 3 h (40.9 ± 13.4 vs 55.8 ± 4.9 ml/min, p = 0.004), 12 h (43.0 ± 3.7 vs 57.8 ± 5.4 ml/min, p = 0.001) with incomplete recovery at 24 h (47.2 ± 5.5 vs 62.1 ± 14.1 ml/min, p = 0.038) as compared to controls, respectively. In vitro bioluminescence displayed transfected Luc-MSCs along the proximal and mid part of the LAD, with limited number (295 ± 101 sry copied/million cardiac cells) of Y-chromosome-MSCs in the infarcted area. Intracoronary injection of SCs results in immediate decrease of AMF, with delayed recovery. The delivery of the SC into the injured myocardium might be hindered by the altered coronary pressure and flow conditions.

Entities:  

Mesh:

Year:  2011        PMID: 21153508     DOI: 10.1007/s12015-010-9213-7

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  16 in total

1.  Imaging the migration of therapeutically delivered cardiac stem cells.

Authors:  Mariann Gyöngyösi; Rayyan Hemetsberger; Susanne Wolbank; Christoph Kaun; Aniko Posa; Terèz Marian; Làszlò Balkay; Miklos Emri; Làszlò Galuska; Pal Mikecz; Zsolt Petrasi; Silvia Charwat; Hani Hemetsberger; Jeronimo Blanco; Gerald Maurer
Journal:  JACC Cardiovasc Imaging       Date:  2010-07

2.  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).

Authors:  Birgit Assmus; Volker Schächinger; Claudius Teupe; Martina Britten; Ralf Lehmann; Natascha Döbert; Frank Grünwald; Alexandra Aicher; Carmen Urbich; Hans Martin; Dieter Hoelzer; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

3.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Authors:  Ketil Lunde; Svein Solheim; Svend Aakhus; Harald Arnesen; Michael Abdelnoor; Torstein Egeland; Knut Endresen; Arnfinn Ilebekk; Arild Mangschau; Jan G Fjeld; Hans Jørgen Smith; Eli Taraldsrud; Haakon Kiil Grøgaard; Reidar Bjørnerheim; Magne Brekke; Carl Müller; Einar Hopp; Asgrimur Ragnarsson; Jan E Brinchmann; Kolbjørn Forfang
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

4.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

5.  Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics.

Authors:  Catalin Toma; William R Wagner; Shivani Bowry; Abigail Schwartz; Flordeliza Villanueva
Journal:  Circ Res       Date:  2008-12-18       Impact factor: 17.367

6.  Intracoronary delivery of mesenchymal stem cells at high flow rates after myocardial infarction improves distal coronary blood flow and decreases mortality in pigs.

Authors:  Raul Llano; Samuel Epstein; Rong Zhou; Hualei Zhang; Damir Hamamdzic; Martin G Keane; Toby Freyman; Robert L Wilensky
Journal:  Catheter Cardiovasc Interv       Date:  2009-02-01       Impact factor: 2.692

7.  Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.

Authors:  Emerson C Perin; Guilherme V Silva; Joao A R Assad; Deborah Vela; L Maximilian Buja; Andre L S Sousa; Silvio Litovsky; Jing Lin; William K Vaughn; Stephanie Coulter; Marlos R Fernandes; James T Willerson
Journal:  J Mol Cell Cardiol       Date:  2007-10-04       Impact factor: 5.000

8.  A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

Authors:  Toby Freyman; Glenn Polin; Hashim Osman; Jody Crary; MinMin Lu; Lan Cheng; Maria Palasis; Robert L Wilensky
Journal:  Eur Heart J       Date:  2006-03-01       Impact factor: 29.983

9.  Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.

Authors:  Sandra Erbs; Axel Linke; Volker Schächinger; Birgit Assmus; Holger Thiele; Klaus-Werner Diederich; Christina Hoffmann; Stefanie Dimmeler; Torsten Tonn; Rainer Hambrecht; Andreas M Zeiher; Gerhard Schuler
Journal:  Circulation       Date:  2007-07-09       Impact factor: 29.690

10.  Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study.

Authors:  Mariann Gyöngyösi; Irene Lang; Markus Dettke; Gilbert Beran; Senta Graf; Heinz Sochor; Noémi Nyolczas; Silvia Charwat; Rayyan Hemetsberger; Günter Christ; István Edes; László Balogh; Korff Thomas Krause; Kai Jaquet; Karl-Heinz Kuck; Imre Benedek; Theodora Hintea; Róbert Kiss; István Préda; Vladimir Kotevski; Hristo Pejkov; Sholeh Zamini; Aliasghar Khorsand; Gottfried Sodeck; Alexandra Kaider; Gerald Maurer; Dietmar Glogar
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-11-11
View more
  4 in total

Review 1.  Imaging: guiding the clinical translation of cardiac stem cell therapy.

Authors:  Patricia K Nguyen; Feng Lan; Yongming Wang; Joseph C Wu
Journal:  Circ Res       Date:  2011-09-30       Impact factor: 17.367

Review 2.  Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.

Authors:  Mariann Gyöngyösi; Nabil Dib
Journal:  Nat Rev Cardiol       Date:  2011-05-17       Impact factor: 32.419

3.  Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery.

Authors:  Katrin Zlabinger; Dominika Lukovic; Rayyan Hemetsberger; Alfred Gugerell; Johannes Winkler; Ljubica Mandic; Denise Traxler; Andreas Spannbauer; Susanne Wolbank; Gerald Zanoni; Christoph Kaun; Aniko Posa; Andrea Gyenes; Zsolt Petrasi; Örs Petnehazy; Imre Repa; Renate Hofer-Warbinek; Rainer de Martin; Florian Gruber; Silvia Charwat; Kurt Huber; Noemi Pavo; Imre J Pavo; Noemi Nyolczas; Dara L Kraitchman; Mariann Gyöngyösi
Journal:  Front Bioeng Biotechnol       Date:  2018-04-04

Review 4.  Stem cell-derived exosomes - an emerging tool for myocardial regeneration.

Authors:  Erzsebet Lazar; Theodora Benedek; Szilamer Korodi; Nora Rat; Jocelyn Lo; Imre Benedek
Journal:  World J Stem Cells       Date:  2018-08-26       Impact factor: 5.326

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.